| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.30B | +46.1% |
| Gross profit | ¥0.03B | — |
| Operating income | ¥-0.05B | — |
| Net income | ¥-0.05B | — |
| Gross margin | 11.1% | Net margin -14.8% |
| Revenue Q/Q | -7.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.27B | 88.9% |
| R&D | ¥0.02B | 7.2% |
| SG&A | ¥0.03B | 8.5% |
| Tax & other | ¥-0.01B | -2.9% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
恒帅股份 ・ 华绿生物 ・ 博亚精工 ・ 万辰集团 ・ 立高食品 ・ 商络电子 ・ 达瑞电子 ・ 深圳瑞捷 ・ 东箭科技 ・ 华利集团 ・ 祥源新材 ・ 中红医疗
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies